| Role |
Name |
Disclosure |
Details |
| Author | Don R Revis Jr, MD, Consulting Staff, Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida College of Medicine | Nothing to disclose | Details | | Medical Editor | Carlos J Lozada, MD, Director of Rheumatology Fellowship Program, Associate Professor, Department of Medicine, Division of Rheumatology and Immunology, Jackson Memorial Medical Center, University of Miami School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Lawrence H Brent, MD, Associate Professor of Medicine, Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center | Genentech Genentch Genentech Abbott Immunology Amgen Wyeth | Details | | CME Editor | Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | Herbert S Diamond, MD, Professor of Medicine, Temple University School of Medicine; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital | medifocus health dialogs Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott, West Penn Allegheny Health System Pfizer Proctor&Gamble, Amgen, Pfizer | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Don R Revis, Jr, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Carlos J Lozada, Medical Editor |
The contributor discloses no conflict of interest. |
|